Shares of Palo Alto, Calif.-based biotechnology company CV Therapeutics Inc. rose Wednesday after the company said its third-quarter loss narrowed on sales of the angina treatment Ranexa and expenses dropped.
From: biz.yahoo.com
CV Therapeutics Shares Rise on 3Q Result
Posted by Ruslan Abuzant at 10:18 AM
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment